CN Patent

CN109922813A — 药物组合物、治疗方法及其用途

Assigned to Boehringer Ingelheim International GmbH · Expires 2019-06-21 · 7y expired

What this patent protects

本发明涉及治疗或预防慢性肾病患者的慢性肾病和心血管疾病的方法，该方法包括向该患者给予恩格列净。

USPTO Abstract

本发明涉及治疗或预防慢性肾病患者的慢性肾病和心血管疾病的方法，该方法包括向该患者给予恩格列净。

Drugs covered by this patent

Patent Metadata

Patent number
CN109922813A
Jurisdiction
CN
Classification
—
Expires
2019-06-21
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.